Elixir Software Ltd. is proud to announce that its CEO and Co-Founder, Dr. Paul Faulder, has been featured in the latest episode of the Pharma Now podcast, where he discusses how iTraX, Elixir’s flagship R&D platform, is redefining collaboration and efficiency in global pharmaceutical research.
In this exclusive interview, Dr. Faulder shares how his experience at AstraZeneca, GSK, and Amgen revealed the limitations of traditional R&D systems, fragmented spreadsheets, siloed communication, and delayed decision-making, and how these challenges inspired the creation of iTraX.
iTraX serves as an “operating system for R&D,” uniting scientists, workflows, and data across multiple sites and partners. The platform enables real-time visibility, streamlined operations, and faster decision-making, empowering research teams to focus on innovation rather than administration.
The platform has already demonstrated measurable impact, helping organizations manage hundreds of thousands of research tasks annually and delivering significant cost and time savings. As Dr. Faulder explains, iTraX’s success lies in its adaptability, intuitive design, and ability to bring order and transparency to complex R&D ecosystems.
